Effect of artificial pancreas treatment on peripheral nerve function in diabetes

Neurology. 1981 Nov;31(11):1375-80. doi: 10.1212/wnl.31.11.1375.

Abstract

To determine whether the complete correction of hyperglycemia of diabetes can rapidly improve abnormal peripheral nerve function, eight hyperglycemic insulin-requiring diabetics underwent 3 days of glucose control with an artificial endocrine pancreas, the BIOSTATOR Glucose Controller. Comparison of neurologic assessment before and after BIOSTATOR treatment showed improvement only in ulnar sensory conduction velocity (+ 3.2 +/- 1.4 meters per second, p less than 0.032) and no significant changes in 24 other nerve conduction measurements, computer-assisted examination, and scored neurologic assessment. Any significant beneficial effect on nerve function resulting from correction of hyperglycemia probably requires more than 3 days to be manifested.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Blood Glucose / analysis
  • Clinical Trials as Topic
  • Diabetes Mellitus / blood
  • Diabetes Mellitus / drug therapy*
  • Diabetes Mellitus / physiopathology
  • Female
  • Humans
  • Insulin Infusion Systems*
  • Male
  • Middle Aged
  • Neural Conduction
  • Peripheral Nerves / physiopathology*
  • Sensory Thresholds
  • Touch

Substances

  • Blood Glucose